Genetically Determined Levels of mTOR-Dependent Circulating Proteins and Risk of Multiple Sclerosis
Abstract Background Results from observational studies indicate an association between circulating levels of mammalian target of rapamycin (mTOR)-dependent circulating proteins and the risk of multiple sclerosis (MS). However, a causal association has not been fully elucidated. Mendelian randomizati...
Main Authors: | Yao-Chen Zhang, Ke-Yi Fan, Qi Wang, Jing-Xi Hu, Qian Wang, He-Yi Zhang, Shan Song, Rong Zhao, Jun Qiao, Sheng-Xiao Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2023-03-01
|
Series: | Neurology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40120-023-00455-y |
Similar Items
-
The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data
by: Aigli G. Vakrakou, et al.
Published: (2022-07-01) -
Overview of Research into mTOR Inhibitors
by: Beibei Mao, et al.
Published: (2022-08-01) -
Expression of mTOR in normal and pathological conditions
by: A Marques-Ramos, et al.
Published: (2023-07-01) -
Causal association between mTOR-dependent circulating protein levels and central precocious puberty: a Mendelian randomization study
by: Yuanxiao Ying, et al.
Published: (2024-03-01) -
Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysis
by: Min Li, et al.
Published: (2019-02-01)